Max Healthcare Institute joined an international research consortium under the Indo-EU COMBAT initiative. This **dengue research initiative** seeks to improve global preparedness for mosquito-borne diseases. Furthermore, the collaboration leverages advanced technology to enhance diagnostic and management frameworks for infectious diseases. The Department of Biotechnology and the European Commission provide significant financial support for this project. Consequently, this partnership represents a major step forward for medical research in India.
### The Indo-EU COMBAT Dengue Research Initiative
This ambitious programme brings together leading institutions from India and Europe. Notably, researchers will combine multi-omics technologies and artificial intelligence to study disease progression. These scientists aim to identify predictive biomarkers that enable earlier diagnosis. Such biological markers are essential for triaging patients at high risk of severe complications. Moreover, the project explores the complex pathogenesis of the virus using cutting-edge molecular models. Therefore, clinicians can expect more precise tools for patient management in the near future.
### Advancing Clinical Outcomes through Multi-Omics
The research focuses on finding early warning markers to improve patient outcomes. Consequently, clinical expertise from India will merge with European scientific capabilities to build scalable solutions. Sandeep Budhiraja and Atul Thatai lead the project as principal investigators at Max Healthcare. Additionally, the BRIC National Institute of Biomedical Genomics coordinates the initiative within India. This data-driven approach will eventually strengthen national surveillance and treatment frameworks for endemic regions. Furthermore, the collaboration highlights the importance of cross-border scientific cooperation in tackling global health threats, which is a core focus for professionals looking to enhance their skills through multispecialty courses.
Frequently Asked Questions
Q1: What is the primary goal of the Indo-EU COMBAT initiative?
The initiative aims to develop technology-driven solutions for understanding and managing dengue. It focuses on identifying predictive biomarkers through AI and multi-omics to improve early diagnosis and patient survival.
Q2: Who are the key participants in this collaboration?
The project involves Max Healthcare Institute, the Karolinska Institute, and the BRIC National Institute of Biomedical Genomics. It also receives support from the European Commission and India’s Department of Biotechnology.
References
- Max Healthcare joins global consortium to advance dengue research under Indo-EUCOMBAT initiative – ETHealthworld
- KI to coordinate EU-funded initiative to combat global dengue epidemic – Karolinska Institutet
- Study Details | NCT06751836 | Innovative Multidisciplinary Strategies for Combating Severe Dengue – ClinicalTrials.gov
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.